| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT06779773 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People… |
Primary endpoint(s) modified |
| 2026-06-09 | NCT06779773 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People… |
Enrollment reduced: 1000 -> 500 participants |
| 2026-06-09 | NCT06779773 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People… |
date change Primary completion pushed: 2030-01-31 -> 2030-10-31 |
| 2026-06-09 | NCT06779773 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People… |
date change Completion pushed: 2030-01-31 -> 2030-10-31 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06970665 | A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With… | Geographic Atrophy | Recruiting |
| Phase 1 | |||
| NCT06961370 | A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics… | Geographic Atrophy | Active, Not Recruiting |
| Not specified | |||
| NCT06779773 | A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People… | Geographic Atrophy | Recruiting |